A5005217359- Transcranial Magnetic Stimulation Studies
- Treatment of Major Depression
- Digital Mental Health Interventions
- Functional Brain Connectivity Studies
Alberta Health Services
2020-2023
Background: Treatment-resistant depression (TRD) is considered one of the major clinical challenges in field psychiatry. An estimated 44% patients with depressive disorder (MDD) do not respond to two consecutive antidepressant therapies, and 33% up four antidepressants. Over 15% all MDD remain refractory any treatment intervention. rTMS a option for TRD. Likewise, iCBT evidence-based, symptom-focused psychotherapy recommended Objective: This study aimed evaluate initial comparative...
Major depression is a severe, disabling, and potentially lethal clinical disorder. Only about half of patients respond to an initial course antidepressant pharmacotherapy. At least 15% all with major depressive disorder (MDD) remain refractory any treatment intervention. By the time that patient has experienced 3 definitive failures, likelihood achieving remission fourth option offered below 10%. Repetitive transcranial magnetic stimulation (rTMS) considered for MDD who are treatment. It not...
<sec> <title>BACKGROUND</title> Major depression is a severe, disabling, and potentially lethal clinical disorder. Only about half of patients respond to an initial course antidepressant pharmacotherapy. At least 15% all with major depressive disorder (MDD) remain refractory any treatment intervention. By the time that patient has experienced 3 definitive failures, likelihood achieving remission fourth option offered below 10%. Repetitive transcranial magnetic stimulation (rTMS) considered...